400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Epigenetics / PARP / 维利帕尼
CAS No.: 912444-00-9
Synonyms: ABT-888;维利帕尼
Veliparib is a potent inhibitor of PARP1 and PARP2 with Ki of 5.2 nM and 2.9 nM, respectively.
生物活性
靶点 | PARP1 Ki:5.2nM | PARP2 Ki:2.9nM |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT00770471 | Brain and Central Nervous Syst... more >>em Tumors Collapse << | Phase 1 | Completed | - | United States, Alabama ... more >> UAB Comprehensive Cancer Center Birmingham, Alabama, United States, 35294-3410 United States, California UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Georgia Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Michigan Josephine Ford Cancer Center at Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, North Carolina Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 United States, Pennsylvania Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 UPMC Cancer Centers Pittsburgh, Pennsylvania, United States, 15232 United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792-6164 Collapse << |
NCT00526617 | Non-hematologic Malignancies ... more >> Metastatic Melanoma Breast Cancer Ovarian Cancer Primary Peritoneal Cancer Fallopian Tube Cancer Hepatocellular Carcinoma Collapse << | Phase 1 | Completed | - | - |
NCT01419548 | Neoplasms | Phase 1 | Withdrawn | - | United States, Maryland ... more >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 United States, Pennsylvania University of Pittsburgh Cancer Center Pittsburgh, Pennsylvania, United States Collapse << |
实验方案
技术信息
CAS号 | 912444-00-9 | 储存条件 |
|
|||||||||
分子式 | C13H16N4O | 运输 | 蓝冰 | |||||||||
分子量 | 244.29 | 别名 | ABT-888;维利帕尼 | |||||||||
溶解度 |
|
动物实验配方 |
|
Cell Lines | Concentration | Assay Type | Time | Activity Description | Data Sources |
---|
697 | - | Growth Inhibition Assay | - | IC50=29.0235 μM | SANGER |
A2780 | - | Growth Inhibition Assay | - | IC50=30.7457 μM | SANGER |
A388 | - | Growth Inhibition Assay | - | IC50=21.9091 μM | SANGER |
A4-Fuk | - | Growth Inhibition Assay | - | IC50=43.5691 μM | SANGER |
ALL-PO | - | Growth Inhibition Assay | - | IC50=47.3791 μM | SANGER |
BALL-1 | - | Growth Inhibition Assay | - | IC50=43.9532 μM | SANGER |
BEN | - | Growth Inhibition Assay | - | IC50=27.9566 μM | SANGER |
BV-173 | - | Growth Inhibition Assay | - | IC50=5.45409 μM | SANGER |
C41 | - | Kinase Assay | 30 min | Inhibition of PARP1 with EC50 of 0.002 μM | 19888760 |
CAL-33 | - | Growth Inhibition Assay | - | IC50=10.434 μM | SANGER |
CAL-54 | - | Growth Inhibition Assay | - | IC50=37.966 μM | SANGER |
Capan1 | - | Growth Inhibition Assay | 72 h | Antiproliferative activity against BRCA2 gene mutated human Capan1 cells with IC50 of 39.7 μM | 24398383 |
ChaGo-K-1 | - | Growth Inhibition Assay | - | IC50=16.5325 μM | SANGER |
COLO-668 | - | Growth Inhibition Assay | - | IC50=17.6294 μM | SANGER |
COLO-680 | - | Growth Inhibition Assay | - | IC50=6.21406 μM | SANGER |
COLO-684 | - | Growth Inhibition Assay | - | IC50=33.3599 μM | SANGER |
CTV-1 | - | Growth Inhibition Assay | - | IC50=25.8969 μM | SANGER |
Daoy | - | Growth Inhibition Assay | - | IC50=19.5649 μM | SANGER |
DEL | - | Growth Inhibition Assay | - | IC50=16.6717 μM | SANGER |
DT40 | - | Cytotoxic Assay | 72 h | Cytotoxicity against chicken BRCA2-deficient DT40 cells | 24922587 |
DU-145 | - | Growth Inhibition Assay | - | IC50=13.9053 μM | SANGER |
ECC10 | - | Growth Inhibition Assay | - | IC50=20.7455 μM | SANGER |
EM-2 | - | Growth Inhibition Assay | - | IC50=29.4901 μM | SANGER |
EoL-1-cell | - | Growth Inhibition Assay | - | IC50=1.0798 μM | SANGER |
EW-13 | - | Growth Inhibition Assay | - | IC50=29.3814 μM | SANGER |
EW-3 | - | Growth Inhibition Assay | - | IC50=14.5565 μM | SANGER |
FaDu | 10 μM | Cytotoxic Assay | 24 h | Reduces the cell viability | 21912620 |
GP5d | - | Growth Inhibition Assay | - | IC50=17.053 μM | SANGER |
H4 | - | Growth Inhibition Assay | - | IC50=37.567 μM | SANGER |
H9 | - | Growth Inhibition Assay | - | IC50=18.2833 μM | SANGER |
HAL-01 | - | Growth Inhibition Assay | - | IC50=9.8862 μM | SANGER |
HCC1187 | - | Growth Inhibition Assay | - | IC50=41.2771 μM | SANGER |
HCC1806 | - | Growth Inhibition Assay | - | IC50=5.75173 μM | SANGER |
HCC1937 | - | Growth Inhibition Assay | - | IC50=24.746 μM | SANGER |
HCC2218 | - | Growth Inhibition Assay | - | IC50=7.79704 μM | SANGER |
HCC70 | - | Growth Inhibition Assay | - | IC50=27.7246 μM | SANGER |
HCT-116 | 0.5 μM | Kinase Assay | 24 h | PARP activity decreases | 23054213 |
HEC-1 | - | Growth Inhibition Assay | - | IC50=12.9196 μM | SANGER |
HLE | - | Growth Inhibition Assay | - | IC50=27.054 μM | SANGER |
IGROV-1 | - | Growth Inhibition Assay | - | IC50=39.3304 μM | SANGER |
Jurkat | - | Kinase Assay | 96 h | Inhibition of PARP1 assessed as reduction of cell viability with EC50 of 3 μM | 23850199 |
JVM-2 | - | Growth Inhibition Assay | - | IC50=42.9207 μM | SANGER |
JVM-3 | - | Growth Inhibition Assay | - | IC50=35.5868 μM | SANGER |
KARPAS-45 | - | Growth Inhibition Assay | - | IC50=41.4818 μM | SANGER |
KASUMI-1 | - | Growth Inhibition Assay | - | IC50=8.89266 μM | SANGER |
KG-1 | - | Growth Inhibition Assay | - | IC50=33.6001 μM | SANGER |
KU812 | - | Growth Inhibition Assay | - | IC50=32.3642 μM | SANGER |
KY821 | - | Growth Inhibition Assay | - | IC50=12.485 μM | SANGER |
KYSE-150 | - | Growth Inhibition Assay | - | IC50=18.9986 μM | SANGER |
L-363 | - | Growth Inhibition Assay | - | IC50=29.4798 μM | SANGER |
LAMA-84 | - | Growth Inhibition Assay | - | IC50=36.7345 μM | SANGER |
LB771 | - | Growth Inhibition Assay | - | IC50=28.8373 μM | SANGER |
LU-139 | - | Growth Inhibition Assay | - | IC50=29.3748 μM | SANGER |
MDA-MB-361 | - | Growth Inhibition Assay | - | IC50=43.8414 μM | SANGER |
MFE-280 | - | Growth Inhibition Assay | - | IC50=33.3889 μM | SANGER |
MHH-NB-11 | - | Growth Inhibition Assay | - | IC50=23.1363 μM | SANGER |
MHH-PREB-1 | - | Growth Inhibition Assay | - | IC50=45.7585 μM | SANGER |
ML-1 | 2.5 μM | Apoptotic Assay | 24 h | Synergistically enhances TRAIL-induced apoptosis in ML-1 cells | 24895135 |
ML-2 | - | Growth Inhibition Assay | - | IC50=49.7856 μM | SANGER |
MN-60 | - | Growth Inhibition Assay | - | IC50=13.5389 μM | SANGER |
MOLT-13 | - | Growth Inhibition Assay | - | IC50=29.3814 μM | SANGER |
MOLT-16 | - | Growth Inhibition Assay | - | IC50=36.952 μM | SANGER |
MOLT-4 | - | Growth Inhibition Assay | - | IC50=42.2538 μM | SANGER |
Mo-T | - | Growth Inhibition Assay | - | IC50=45.6389 μM | SANGER |
MV-4-11 | - | Growth Inhibition Assay | - | IC50=35.8499 μM | SANGER |
NB14 | - | Growth Inhibition Assay | - | IC50=40.7031 μM | SANGER |
NCI-H1693 | - | Growth Inhibition Assay | - | IC50=27.2898 μM | SANGER |
NCI-H2029 | - | Growth Inhibition Assay | - | IC50=26.4238 μM | SANGER |
NCI-H510A | - | Growth Inhibition Assay | - | IC50=47.9034 μM | SANGER |
NCI-H720 | - | Growth Inhibition Assay | - | IC50=8.43603 μM | SANGER |
NCI-SNU-5 | - | Growth Inhibition Assay | - | IC50=3.12841 μM | SANGER |
NKM-1 | - | Growth Inhibition Assay | - | IC50=18.5119 μM | SANGER |
OS-RC-2 | - | Growth Inhibition Assay | - | IC50=15.9589 μM | SANGER |
PC-3 | 10 μM | Growth Inhibition Assay | - | Induces a significant inhibition in colony formation | 21571912 |
Ramos-2G6-4C10 | - | Growth Inhibition Assay | - | IC50=12.4752 μM | SANGER |
RPMI-8226 | - | Growth Inhibition Assay | - | IC50=16.2042 μM | SANGER |
RS4-11 | - | Growth Inhibition Assay | - | IC50=30.4241 μM | SANGER |
SBC-1 | - | Growth Inhibition Assay | - | IC50=41.3063 μM | SANGER |
SK-MEL-1 | - | Growth Inhibition Assay | - | IC50=12.4663 μM | SANGER |
SK-MEL-24 | - | Growth Inhibition Assay | - | IC50=7.81924 μM | SANGER |
SK-NEP-1 | - | Growth Inhibition Assay | - | IC50=13.166 μM | SANGER |
SW982 | - | Growth Inhibition Assay | - | IC50=38.0998 μM | SANGER |
T47D | - | Growth Inhibition Assay | - | IC50=37.7018 μM | SANGER |
T98G | - | Growth Inhibition Assay | - | IC50=44.8517 μM | SANGER |
TGBC11TKB | - | Growth Inhibition Assay | - | IC50=25.6863 μM | SANGER |
UM-SCC1 | 10 μM | Cytotoxic Assay | 24 h | Reduces the cell viability | 21912620 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT00770471 | Brain and Central Nervous Syst... more >>em Tumors Collapse << | Phase 1 | Completed | - | United States, Alabama ... more >> UAB Comprehensive Cancer Center Birmingham, Alabama, United States, 35294-3410 United States, California UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Georgia Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Michigan Josephine Ford Cancer Center at Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, North Carolina Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 United States, Pennsylvania Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 UPMC Cancer Centers Pittsburgh, Pennsylvania, United States, 15232 United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792-6164 Collapse << |
NCT00526617 | Non-hematologic Malignancies ... more >> Metastatic Melanoma Breast Cancer Ovarian Cancer Primary Peritoneal Cancer Fallopian Tube Cancer Hepatocellular Carcinoma Collapse << | Phase 1 | Completed | - | - |
NCT01419548 | Neoplasms | Phase 1 | Withdrawn | - | United States, Maryland ... more >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 United States, Pennsylvania University of Pittsburgh Cancer Center Pittsburgh, Pennsylvania, United States Collapse << |
NCT02921256 | Rectal Adenocarcinoma ... more >> Stage II Rectal Cancer AJCC v7 Stage III Rectal Cancer AJCC v7 Collapse << | Phase 2 | Recruiting | - | - |
NCT01026493 | Brain and Central Nervous Syst... more >>em Tumors Collapse << | Phase 1 Phase 2 | Completed | - | United States, California ... more >> Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States, 92093-0658 Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 United States, Hawaii Leeward Radiation Oncology 'Ewa Beach, Hawaii, United States, 96706 Cancer Research Center of Hawaii Honolulu, Hawaii, United States, 96813 Queen's Cancer Institute at Queen's Medical Center Honolulu, Hawaii, United States, 96813 Hawaii Medical Center - East Honolulu, Hawaii, United States, 96817 United States, Illinois University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637-1470 United States, Kansas CCOP - Kansas City Prairie Village, Kansas, United States, 66208 United States, Kentucky Central Baptist Hospital Lexington, Kentucky, United States, 40503-9985 Louisville Oncology at Norton Cancer Institute - Louisville Louisville, Kentucky, United States, 40202 United States, Mississippi Regional Cancer Center at Singing River Hospital Pascagoula, Mississippi, United States, 39581 United States, Nevada Renown Institute for Cancer at Renown Regional Medical Center Reno, Nevada, United States, 89502 United States, New Hampshire Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756-0002 United States, New Jersey Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick, New Jersey, United States, 08903 United States, New York Highland Hospital of Rochester Rochester, New York, United States, 14620 James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States, 14642 United States, Oregon Legacy Good Samaritan Hospital & Comprehensive Cancer Center Portland, Oregon, United States, 97210 Collapse << |
NCT01026493 | - | - | Completed | - | - |
NCT01063816 | Advanced Solid Tumors | Phase 1 | Completed | - | - |
NCT00994071 | Medulloblastoma ... more >> Pontine Glioma Ependymoma Astrocytoma PNET Collapse << | Phase 1 | Completed | - | United States, Maryland ... more >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Collapse << |
NCT00387608 | Leukemia Lymp... more >>homa Unspecified Adult Solid Tumor, Protocol Specific Collapse << | Phase 1 | Completed | - | United States, Maryland ... more >> Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States, 20892-1182 Collapse << |
NCT00553189 | Solid Tumors ... more >>Lymphomas Collapse << | Phase 1 | Completed | - | United States, Maryland ... more >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Collapse << |
NCT02032277 | Triple Negative Breast Cancer | Phase 3 | Active, not recruiting | November 2, 2020 | - |
NCT00535119 | Adult Solid Neoplasm ... more >> BRCA1 Mutation Carrier BRCA2 Mutation Carrier Hereditary Breast and Ovarian Cancer Syndrome Collapse << | Phase 1 | Completed | - | United States, California ... more >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 USC / Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 United States, Georgia Emory University/Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Pennsylvania Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States, 15232 University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 Collapse << |
NCT01618357 | Breast Cancer | Phase 1 | Recruiting | December 31, 2019 | United States, Indiana ... more >> Indiana University Health Hospital Recruiting Indianapolis, Indiana, United States, 46202 Contact: Amy Miller 317-278-7614 amym@iu.edu Principal Investigator: Richard Zellars, MD Indiana University Health Melvin and Bren Simon Cancer Center Recruiting Indianapolis, Indiana, United States, 46202 Contact: Amy Miller 317-278-7614 amym@iu.edu Principal Investigator: Richard Zellars, MD Sidney and Lois Eskenazi Hospital Recruiting Indianapolis, Indiana, United States, 46202 Contact: Amy Miller 317-278-7614 amym@iu.edu Spring Mill Medical Center Recruiting Indianapolis, Indiana, United States, 46290 Contact: Amy Miller 317-278-7614 amym@iu.edu Principal Investigator: Richard Zellars, MD United States, Maryland The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting Baltimore, Maryland, United States, 21231 Contact: Amber Bauchle 317-274-2869 adbauchl@iu.edu Collapse << |
NCT01113957 | Ovarian Cancer | Phase 2 | Completed | - | - |
NCT02470585 | Ovarian Cancer ... more >> Ovarian Neoplasm Collapse << | Phase 3 | Active, not recruiting | May 28, 2020 | - |
NCT00989651 | Fallopian Tube Carcinosarcoma ... more >> Fallopian Tube Clear Cell Adenocarcinoma Fallopian Tube Endometrioid Adenocarcinoma Fallopian Tube Mucinous Adenocarcinoma Fallopian Tube Serous Neoplasm Fallopian Tube Transitional Cell Carcinoma Fallopian Tube Undifferentiated Carcinoma Ovarian Brenner Tumor Ovarian Carcinosarcoma Ovarian Clear Cell Adenocarcinoma Ovarian Endometrioid Adenocarcinoma Ovarian Mucinous Adenocarcinoma Ovarian Seromucinous Tumor Ovarian Serous Adenocarcinoma Ovarian Transitional Cell Carcinoma Ovarian Undifferentiated Carcinoma Primary Peritoneal Serous Adenocarcinoma Stage IIA Fallopian Tube Cancer AJCC v6 and v7 Stage IIA Ovarian Cancer AJCC V6 and v7 Stage IIB Fallopian Tube Cancer AJCC v6 and v7 Stage IIB Ovarian Cancer AJCC v6 and v7 Stage IIC Fallopian Tube Cancer AJCC v6 and v7 Stage IIC Ovarian Cancer AJCC v6 and v7 Stage IIIA Fallopian Tube Cancer AJCC v7 Stage IIIA Ovarian Cancer AJCC v6 and v7 Stage IIIA Primary Peritoneal Cancer AJCC v7 Stage IIIB Fallopian Tube Cancer AJCC v7 Stage IIIB Ovarian Cancer AJCC v6 and v7 Stage IIIB Primary Peritoneal Cancer AJCC v7 Stage IIIC Fallopian Tube Cancer AJCC v7 Stage IIIC Ovarian Cancer AJCC v6 and v7 Stage IIIC Primary Peritoneal Cancer AJCC v7 Stage IV Fallopian Tube Cancer AJCC v6 and v7 Stage IV Ovarian Cancer AJCC v6 and v7 Stage IV Primary Peritoneal Cancer AJCC v7 Collapse << | Phase 1 | Active, not recruiting | - | - |
NCT00946335 | Childhood Atypical Teratoid/Rh... more >>abdoid Tumor Childhood Central Nervous System Germ Cell Tumor Childhood Choroid Plexus Tumor Childhood Craniopharyngioma Childhood Ependymoblastoma Childhood Grade I Meningioma Childhood Grade II Meningioma Childhood Grade III Meningioma Childhood High-grade Cerebellar Astrocytoma Childhood High-grade Cerebral Astrocytoma Childhood Infratentorial Ependymoma Childhood Low-grade Cerebellar Astrocytoma Childhood Low-grade Cerebral Astrocytoma Childhood Medulloepithelioma Childhood Mixed Glioma Childhood Oligodendroglioma Childhood Supratentorial Ependymoma Recurrent Childhood Brain Stem Glioma Recurrent Childhood Brain Tumor Recurrent Childhood Cerebellar Astrocytoma Recurrent Childhood Cerebral Astrocytoma Recurrent Childhood Ependymoma Recurrent Childhood Medulloblastoma Recurrent Childhood Pineoblastoma Recurrent Childhood Spinal Cord Neoplasm Recurrent Childhood Subependymal Giant Cell Astrocytoma Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor Recurrent Childhood Visual Pathway and Hypothalamic Glioma Collapse << | Phase 1 | Completed | - | United States, Tennessee ... more >> Pediatric Brain Tumor Consortium Memphis, Tennessee, United States, 38105 Collapse << |
NCT01818063 | Estrogen Receptor-negative Bre... more >>ast Cancer HER2-negative Breast Cancer Progesterone Receptor-negative Breast Cancer Stage II Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Triple-negative Breast Cancer Collapse << | Phase 2 | Active, not recruiting | April 30, 2019 | United States, Maryland ... more >> Walter Reed National Military Medical Center Bethesda, Maryland, United States, 20889 United States, Pennsylvania Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Reading Hospital Reading, Pennsylvania, United States, 19611 Collapse << |
NCT01818063 | - | - | Active, not recruiting | - | - |
NCT01266447 | - | - | Completed | - | - |
NCT01445522 | Neoplasms Lym... more >>phoma Collapse << | Phase 1 | Completed | - | United States, California ... more >> City of Hope National Medical Center Duarte, California, United States, 91010 United States, Maryland National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Collapse << |
NCT01085422 | Prostate Cancer | Phase 1 | Completed | - | - |
NCT00740805 | Ann Arbor Stage III Non-Hodgki... more >>n Lymphoma Ann Arbor Stage IV Non-Hodgkin Lymphoma Solid Neoplasm Collapse << | Phase 1 | Active, not recruiting | - | United States, New Jersey ... more >> Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 Collapse << |
NCT02890355 | Metastatic Pancreatic Adenocar... more >>cinoma Recurrent Pancreatic Carcinoma Stage IV Pancreatic Cancer AJCC v6 and v7 Collapse << | Phase 2 | Active, not recruiting | - | - |
NCT00576654 | Advanced Malignant Solid Neopl... more >>asm Estrogen Receptor Negative HER2/Neu Negative Hodgkin Lymphoma Metastatic Malignant Neoplasm Metastatic Malignant Solid Neoplasm Non-Hodgkin Lymphoma Progesterone Receptor Negative Stage III Breast Cancer AJCC v7 Stage III Colon Cancer AJCC v7 Stage III Lung Cancer AJCC v7 Stage III Ovarian Cancer AJCC v6 and v7 Stage III Pancreatic Cancer AJCC v6 and v7 Stage IIIA Breast Cancer AJCC v7 Stage IIIA Colon Cancer AJCC v7 Stage IIIA Ovarian Cancer AJCC v6 and v7 Stage IIIB Breast Cancer AJCC v7 Stage IIIB Colon Cancer AJCC v7 Stage IIIB Ovarian Cancer AJCC v6 and v7 Stage IIIC Breast Cancer AJCC v7 Stage IIIC Colon Cancer AJCC v7 Stage IIIC Ovarian Cancer AJCC v6 and v7 Stage IV Breast Cancer AJCC v6 and v7 Stage IV Colon Cancer AJCC v7 Stage IV Lung Cancer AJCC v7 Stage IV Ovarian Cancer AJCC v6 and v7 Stage IV Pancreatic Cancer AJCC v6 and v7 Stage IVA Colon Cancer AJCC v7 Stage IVB Colon Cancer AJCC v7 Triple-Negative Breast Carcinoma Unresectable Malignant Neoplasm Unresectable Solid Neoplasm Collapse << | Phase 1 | Active, not recruiting | - | United States, Connecticut ... more >> Yale University New Haven, Connecticut, United States, 06520 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Michigan Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States, 48201 Collapse << |
NCT01051596 | Colorectal Cancer | Phase 2 | Completed | - | United States, District of Col... more >>umbia Georgetown University Medical Center Washington, District of Columbia, United States, 20008 Collapse << |
NCT01266447 | Cervical Adenocarcinoma ... more >> Cervical Adenosquamous Carcinoma Cervical Small Cell Carcinoma Cervical Squamous Cell Carcinoma Recurrent Cervical Carcinoma Stage III Cervical Cancer Stage IVA Cervical Cancer Stage IVB Cervical Cancer Collapse << | Phase 2 | Completed | - | - |
NCT01638546 | Recurrent Small Cell Lung Carc... more >>inoma Collapse << | Phase 2 | Completed | - | United States, Florida ... more >> Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Georgia Emory University/Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Maryland Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States, 21224 Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 United States, Virginia Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States, 23298 Collapse << |
NCT00804908 | - | - | Completed | - | - |
NCT01617928 | Solid Tumors | Phase 1 | Completed | - | Japan ... more >> Site Reference ID/Investigator# 68622 Tokyo, Japan Collapse << |
NCT01251874 | BRCA1 Gene Mutation ... more >> BRCA2 Gene Mutation Estrogen Receptor Negative Estrogen Receptor Positive HER2/Neu Negative Progesterone Receptor Negative Progesterone Receptor Positive Recurrent Breast Carcinoma Stage IIIB Breast Cancer AJCC v7 Stage IIIC Breast Cancer AJCC v7 Stage IV Breast Cancer AJCC v6 and v7 Triple-Negative Breast Carcinoma Collapse << | Phase 1 | Completed | - | United States, New York ... more >> Montefiore Medical Center-Einstein Campus Bronx, New York, United States, 10461 Montefiore Medical Center - Moses Campus Bronx, New York, United States, 10467 United States, Ohio Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Collapse << |
NCT01459380 | Ovarian Clear Cell Cystadenoca... more >>rcinoma Ovarian Endometrioid Adenocarcinoma Ovarian Seromucinous Carcinoma Ovarian Serous Cystadenocarcinoma Recurrent Fallopian Tube Carcinoma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Undifferentiated Ovarian Carcinoma Collapse << | Phase 1 | Completed | - | United States, Colorado ... more >> University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States, 80045 United States, Georgia Augusta University Medical Center Augusta, Georgia, United States, 30912 United States, Illinois University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 United States, Iowa University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States, 52242 United States, Maryland Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Hillcrest Hospital Cancer Center Mayfield Heights, Ohio, United States, 44124 United States, Oklahoma University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States, 73104 United States, Rhode Island Women and Infants Hospital Providence, Rhode Island, United States, 02905 United States, Wisconsin Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Collapse << |
NCT00804908 | Melanoma Meta... more >>static Melanoma Skin Cancer Collapse << | Phase 2 | Completed | - | - |
NCT01306032 | - | - | Completed | - | - |
NCT01306032 | Ovarian Cancer ... more >> Primary Peritoneal Cancer Serous Carcinoma Cancer Triple-Negative Breast Cancer Fallopian Tube Cancer Collapse << | Phase 2 | Completed | - | United States, California ... more >> University of California, Davis Davis, California, United States, 95616 United States, Florida H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Maryland National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 United States, Minnesota Mayo Clinic, Rochester Rochester, Minnesota, United States, 55905 United States, New York Montefiore Medical Center Bronx, New York, United States, 10467 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10021 United States, Ohio Ohio State University Columbus, Ohio, United States, 43210-1240 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030-4096 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Collapse << |
NCT01638546 | - | - | Completed | - | - |
NCT02152982 | Glioblastoma ... more >>Gliosarcoma Collapse << | Phase 2 Phase 3 | Active, not recruiting | - | - |
NCT01642251 | Extensive Stage Small Cell Lun... more >>g Carcinoma Large Cell Lung Carcinoma Neuroendocrine Carcinoma Small Cell Carcinoma Stage IV Non-Small Cell Lung Cancer AJCC v7 Collapse << | Phase 1 Phase 2 | Active, not recruiting | - | - |
NCT02305758 | Untreated Metastatic Colorecta... more >>l Cancer Collapse << | Phase 2 | Completed | - | - |
NCT00649207 | Brain Diseases ... more >> Brain Neoplasms Central Nervous System Diseases Neoplasm Metastasis Nervous System Neoplasms Collapse << | Phase 1 | Completed | - | United States, Georgia ... more >> Site Reference ID/Investigator# 8334 Atlanta, Georgia, United States, 30322 United States, Illinois Site Reference ID/Investigator# 52462 Chicago, Illinois, United States, 60611 United States, Kansas Site Reference ID/Investigator# 24483 Kansas City, Kansas, United States, 66160 United States, Maryland Site Reference ID/Investigator# 7180 Baltimore, Maryland, United States, 21231-2410 United States, Michigan Site Reference ID/Investigator# 19021 Detroit, Michigan, United States, 48202-2689 United States, Pennsylvania Site Reference ID/Investigator# 6344 Philadelphia, Pennsylvania, United States, 19111 United States, Wisconsin Site Reference ID/Investigator# 6653 Madison, Wisconsin, United States, 53792 Canada Site Reference ID/Investigator# 18542 Toronto, Canada, M5G 2M9 Puerto Rico Site Reference ID/Investigator# 46322 Ponce, Puerto Rico, 00716 Collapse << |
NCT02831179 | Functional Pancreatic Neuroend... more >>ocrine Tumor Malignant Somatostatinoma Merkel Cell Carcinoma Metastatic Adrenal Gland Pheochromocytoma Metastatic Carcinoid Tumor Multiple Endocrine Neoplasia Type 1 Multiple Endocrine Neoplasia Type 2A Multiple Endocrine Neoplasia Type 2B Neuroendocrine Neoplasm Non-Functional Pancreatic Neuroendocrine Tumor Pancreatic Glucagonoma Pancreatic Insulinoma Recurrent Adrenal Cortex Carcinoma Recurrent Adrenal Gland Pheochromocytoma Recurrent Merkel Cell Carcinoma Somatostatin-Producing Neuroendocrine Tumor Stage III Adrenal Cortex Carcinoma Stage III Thyroid Gland Medullary Carcinoma Stage IIIA Merkel Cell Carcinoma Stage IIIB Merkel Cell Carcinoma Stage IV Adrenal Cortex Carcinoma Stage IV Merkel Cell Carcinoma Stage IVA Thyroid Gland Medullary Carcinoma Stage IVB Thyroid Gland Medullary Carcinoma Stage IVC Thyroid Gland Medullary Carcinoma Thymic Carcinoid Tumor VIP-Producing Neuroendocrine Tumor Well Differentiated Adrenal Cortex Carcinoma Zollinger Ellison Syndrome Collapse << | Phase 1 | Withdrawn(Loss of funding supp... more >>ort) Collapse << | February 2020 | - |
NCT01154426 | Adult Solid Neoplasm ... more >> BRCA1 Mutation Carrier BRCA2 Mutation Carrier Collapse << | Phase 1 | Completed | - | United States, Pennsylvania ... more >> Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 UPMC-Magee Womens Hospital Pittsburgh, Pennsylvania, United States, 15213 University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States, 15232 University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 Collapse << |
NCT01711541 | Head and Neck Squamous Cell Ca... more >>rcinoma Stage IVA Oropharyngeal Carcinoma AJCC v7 Stage IVB Oropharyngeal Carcinoma AJCC v7 Collapse << | Phase 1 Phase 2 | Active, not recruiting | - | United States, Illinois ... more >> Northwestern University Chicago, Illinois, United States, 60611 University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 NorthShore University HealthSystem-Evanston Hospital Evanston, Illinois, United States, 60201 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, North Carolina UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 Collapse << |
NCT03400306 | Cancer - Ovarian | Phase 1 | Not yet recruiting | May 24, 2022 | United States, Michigan ... more >> Karmanos Cancer Center /ID# 200136 Not yet recruiting Detroit, Michigan, United States, 48201 United States, Oklahoma University of Oklahoma /ID# 171276 Not yet recruiting Tulsa, Oklahoma, United States, 74135-2527 United States, Rhode Island Lifespan Cancer Institute /ID# 200130 Not yet recruiting Providence, Rhode Island, United States, 02903-4923 United States, Utah Huntsman Cancer Institute /ID# 200135 Not yet recruiting Salt Lake City, Utah, United States, 84112-5500 Denmark Herlev Hospital /ID# 201073 Not yet recruiting Herlev, Hovedstaden, Denmark, 2730 Netherlands Antoni van Leeuwenhoek /ID# 202356 Not yet recruiting Amsterdam, Noord-Holland, Netherlands, 1066 CX Erasmus Medisch Centrum /ID# 201555 Not yet recruiting Rotterdam, Netherlands, 3015 CE Collapse << |
NCT02985658 | - | - | - | - | United States, Washington ... more >> Seattle Cancer Care Allliance Seattle, Washington, United States, 98109 Contact: Jennifer Specht, MD 206-606-6329 Collapse << |
NCT02305758 | - | - | Completed | - | - |
NCT03289910 | Acute Myeloid Leukemia ... more >> Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative Chronic Myelomonocytic Leukemia Essential Thrombocythemia Myelodysplastic/Myeloproliferative Neoplasm Myelofibrosis Polycythemia Vera Recurrent Adult Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Collapse << | Phase 2 | Recruiting | June 1, 2020 | United States, Maryland ... more >> Johns Hopkins University/Sidney Kimmel Cancer Center Recruiting Baltimore, Maryland, United States, 21287 Contact: Site Public Contact 410-955-8804 jhcccro@jhmi.edu Principal Investigator: Keith W. Pratz Collapse << |
NCT01576172 | Castration Levels of Testoster... more >>one Castration-Resistant Prostate Carcinoma PSA Progression Recurrent Prostate Carcinoma Stage IV Prostate Cancer AJCC v7 Collapse << | Phase 2 | Active, not recruiting | - | United States, California ... more >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 USC / Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 City of Hope South Pasadena South Pasadena, California, United States, 91030 United States, Illinois University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 NorthShore University HealthSystem-Evanston Hospital Evanston, Illinois, United States, 60201 United States, Indiana Indiana University/Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 United States, Maryland Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 United States, New Jersey Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 United States, North Carolina UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 United States, Washington University of Washington Medical Center Seattle, Washington, United States, 98195 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Collapse << |
NCT01506609 | Metastatic Breast Cancer | Phase 2 | Active, not recruiting | May 30, 2019 | - |
NCT01386385 | Large Cell Lung Carcinoma ... more >> Lung Adenocarcinoma Lung Adenocarcinoma, Mixed Subtype Minimally Invasive Lung Adenocarcinoma Squamous Cell Lung Carcinoma Stage III Non-Small Cell Lung Cancer AJCC v7 Stage IIIA Non-Small Cell Lung Cancer AJCC v7 Stage IIIB Lung Non-Small Cell Cancer AJCC v7 Collapse << | Phase 1 Phase 2 | Active, not recruiting | January 2, 2021 | - |
NCT01281852 | Cervical Adenocarcinoma ... more >> Cervical Adenosquamous Carcinoma Cervical Squamous Cell Carcinoma, Not Otherwise Specified Recurrent Cervical Carcinoma Stage IVB Cervical Cancer Collapse << | Phase 1 | Completed | - | - |
NCT01281150 | Adult Solid Neoplasm ... more >> Estrogen Receptor Negative Estrogen Receptor Positive HER2/Neu Negative Male Breast Carcinoma Progesterone Receptor Negative Recurrent Breast Carcinoma Stage IIIB Breast Cancer Stage IIIC Breast Cancer Stage IV Breast Cancer Triple-Negative Breast Carcinoma Collapse << | Phase 1 | Completed | - | United States, Pennsylvania ... more >> Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 UPMC-Magee Womens Hospital Pittsburgh, Pennsylvania, United States, 15213 University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States, 15232 Collapse << |
NCT02264990 | Non-squamous Non-small Cell Lu... more >>ng Cancer Collapse << | Phase 3 | Active, not recruiting | July 26, 2019 | - |
NCT01012817 | Metastatic Malignant Solid Neo... more >>plasm Recurrent Fallopian Tube Carcinoma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Unresectable Solid Neoplasm Collapse << | Phase 1 Phase 2 | Suspended(Other - assess toxic... more >>ity and perform interim analysis.) Collapse << | - | United States, Arizona ... more >> Mayo Clinic Hospital Phoenix, Arizona, United States, 85054 Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, California University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 United States, Colorado University of Colorado Hospital Aurora, Colorado, United States, 80045 United States, Florida Mayo Clinic in Florida Jacksonville, Florida, United States, 32224-9980 United States, Illinois University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 UC Comprehensive Cancer Center at Silver Cross New Lenox, Illinois, United States, 60451 University of Chicago Medicine-Orland Park Orland Park, Illinois, United States, 60462 United States, Kansas University of Kansas Clinical Research Center Fairway, Kansas, United States, 66205 United States, Kentucky University of Kentucky/Markey Cancer Center Lexington, Kentucky, United States, 40536 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Pennsylvania University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States, 15232 United States, Texas Parkland Memorial Hospital Dallas, Texas, United States, 75235 UT Southwestern/Simmons Cancer Center-Dallas Dallas, Texas, United States, 75390 United States, Utah Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States, 84112 Collapse << |
NCT03227016 | Small Cell Lung Cancer SCLC | Phase 1 | Recruiting | August 2020 | Germany ... more >> Klinik München Gauting Recruiting München Gauting, Germany Contact: Joachim von Pawel, MD Collapse << |
NCT02033551 | Breast Cancer ... more >> Ovarian Cancer Colon Cancer Lung Cancer Gastric Cancer Solid Tumors Collapse << | Phase 1 | Completed | - | United States, Arizona ... more >> Site Reference ID/Investigator# 117416 Scottsdale, Arizona, United States, 85258 United States, Texas Site Reference ID/Investigator# 117415 San Antonio, Texas, United States, 78229 Netherlands Site Reference ID/Investigator# 117337 Groningen, Netherlands, 9713 GZ Site Reference ID/Investigator# 117338 Maastricht, Netherlands, 6229 HX Spain Site Reference ID/Investigator# 117451 Madrid, Spain, 28050 Collapse << |
NCT01749397 | Stage IV Fallopian Tube Cancer... more >> AJCC v6 and v7 Stage IV Ovarian Cancer AJCC v6 and v7 Stage IV Primary Peritoneal Cancer AJCC v7 Collapse << | Phase 1 | Active, not recruiting | - | United States, Arizona ... more >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, Maryland Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Missouri Siteman Cancer Center at Washington University Saint Louis, Missouri, United States, 63110 Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Collapse << |
NCT01514201 | Anaplastic Astrocytoma ... more >> Brain Stem Glioma Childhood Mixed Glioma Fibrillary Astrocytoma Giant Cell Glioblastoma Glioblastoma Gliosarcoma Untreated Childhood Anaplastic Astrocytoma Untreated Childhood Brain Stem Glioma Untreated Childhood Fibrillary Astrocytoma Untreated Childhood Giant Cell Glioblastoma Untreated Childhood Glioblastoma Untreated Childhood Gliosarcoma Collapse << | Phase 1 Phase 2 | Completed | - | United States, California ... more >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027 Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States, 94304 United States, District of Columbia Children's National Medical Center Washington, District of Columbia, United States, 20010 United States, Illinois Lurie Children's Hospital-Chicago Chicago, Illinois, United States, 60611 United States, Maryland National Institutes of Health Clinical Center Bethesda, Maryland, United States, 20892 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 United States, Pennsylvania Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania, United States, 15224 United States, Tennessee Pediatric Brain Tumor Consortium Memphis, Tennessee, United States, 38105 St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas Texas Children's Hospital Houston, Texas, United States, 77030 Collapse << |
NCT01326702 | Adult B Acute Lymphoblastic Le... more >>ukemia Adult Nasal Type Extranodal NK/T-Cell Lymphoma Adult Solid Neoplasm Anaplastic Large Cell Lymphoma Angioimmunoblastic T-Cell Lymphoma Chronic Lymphocytic Leukemia Cutaneous B-Cell Non-Hodgkin Lymphoma Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Hepatosplenic T-Cell Lymphoma Intraocular Lymphoma Lymphomatous Involvement of Non-Cutaneous Extranodal Site Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma Nodal Marginal Zone Lymphoma Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-Cell Leukemia/Lymphoma Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides and Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Hairy Cell Leukemia Refractory Plasma Cell Myeloma Small Intestinal Lymphoma Splenic Marginal Zone Lymphoma Testicular Lymphoma Waldenstrom Macroglobulinemia Collapse << | Phase 1 Phase 2 | Completed | - | United States, New York ... more >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Collapse << |
NCT01489865 | Metastatic Pancreatic Cancer | Phase 1 Phase 2 | Recruiting | December 2019 | United States, District of Col... more >>umbia Georgetown Lombardi Comprehensive Cancer Center Recruiting Washington, District of Columbia, United States, 20007 Contact: Sarah Parenti 202-687-8350 sep88@georgetown.edu Contact: Lisa Ley, RN MSN 202-687-6653 leyl@georgetown.edu Principal Investigator: Michael Pishvaian, MD PhD Collapse << |
NCT01560104 | Non-Small -Cell Lung Cancer | Phase 2 | Completed | - | - |
NCT01264432 | Adult Solid Neoplasm ... more >> Peritoneal Carcinomatosis Recurrent Fallopian Tube Carcinoma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Collapse << | Phase 1 | Completed | - | United States, Maryland ... more >> University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 Canada, Ontario University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Collapse << |
NCT01585805 | BRCA1 Gene Mutation ... more >> BRCA2 Gene Mutation Metastatic Pancreatic Adenocarcinoma PALB2 Gene Mutation Pancreatic Adenocarcinoma Recurrent Pancreatic Carcinoma Stage III Pancreatic Cancer AJCC v6 and v7 Stage IV Pancreatic Cancer AJCC v6 and v7 Collapse << | Phase 2 | Recruiting | - | United States, Illinois ... more >> University of Chicago Comprehensive Cancer Center Recruiting Chicago, Illinois, United States, 60637 Contact: Hedy L. Kindler 773-702-0360 hkindler@medicine.bsd.uchicago.edu Principal Investigator: Hedy L. Kindler Ingalls Memorial Hospital Recruiting Harvey, Illinois, United States, 60426 Contact: Mark F. Kozloff 708-339-4800 mkozloff@bsd.uchicago.edu Principal Investigator: Mark F. Kozloff United States, Michigan University of Michigan Comprehensive Cancer Center Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Mark M. Zalupski 734-615-3969 zalupski@umich.edu Principal Investigator: Mark M. Zalupski United States, Missouri Mercy Hospital Saint Louis Completed Saint Louis, Missouri, United States, 63141 United States, New Jersey Memorial Sloan Kettering Basking Ridge Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Han Xiao 212-639-7202 Sub-Investigator: Han Xiao Sub-Investigator: Sree B. Chalasani Sub-Investigator: Afsheen Iqbal United States, New York Memorial Sloan Kettering Commack Recruiting Commack, New York, United States, 11725 Contact: Jahan Aghalar 212-639-7202 Sub-Investigator: Jahan Aghalar Sub-Investigator: Avni M. Desai Sub-Investigator: Juliana W. Eng Sub-Investigator: John J. Fiore Sub-Investigator: Stuart M. Lichtman Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Parisa Momtaz kashanie@mskcc.org Sub-Investigator: Parisa Momtaz Sub-Investigator: Philip C. Caron Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Eileen M. O'Reilly 646-888-4182 oreillye@mskcc.org Principal Investigator: Eileen M. O'Reilly Memorial Sloan Kettering Rockville Centre Recruiting Rockville Centre, New York, United States, 11570 Contact: Arlyn J. Apollo 212-639-7202 Sub-Investigator: Arlyn J. Apollo Sub-Investigator: Pamela R. Drullinsky Sub-Investigator: Zoe Goldberg Sub-Investigator: Kenneth K. Ng Sub-Investigator: Tiffany Troso-Sandoval Canada, Ontario University Health Network-Princess Margaret Hospital Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Neesha Dhani 416-946-4501 neesha.dhani@uhn.ca Principal Investigator: Neesha Dhani Israel Shaare Zedek Medical Center Recruiting Jerusalem, Israel, 91031 Contact: Amiel Segal 972-2-666-6331 segal@szmc.org.il Principal Investigator: Amiel Segal Chaim Sheba Medical Center Recruiting Tel Hashomer, Israel, 52621 Contact: Talia Golan 972-3-530-3030 tailia.golan@sheba.health.gov.il Principal Investigator: Talia Golan Collapse << |
NCT01366144 | Breast Carcinoma ... more >> Carcinoma of Unknown Primary Origin Endometrial Carcinoma Esophageal Carcinoma Lung Carcinoma Malignant Head and Neck Neoplasm Melanoma Ovarian Carcinoma Renal Pelvis and Ureter Urothelial Carcinoma Testicular Lymphoma Collapse << | Phase 1 | Suspended(Other - Per CTEP Act... more >>ion Letter) Collapse << | - | United States, California ... more >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 City of Hope South Pasadena South Pasadena, California, United States, 91030 United States, Florida Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Georgia Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Maryland Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Michigan Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, New Jersey Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 United States, New York Montefiore Medical Center-Weiler Hospital Bronx, New York, United States, 10461 Montefiore Medical Center - Moses Campus Bronx, New York, United States, 10467 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 United States, Pennsylvania Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States, 15232 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Collapse << |
NCT01205828 | Hepatocellular Carcinoma | Phase 2 | Terminated(Lack of efficacy) | - | United States, District of Col... more >>umbia Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Washington, District of Columbia, United States, 20007 Collapse << |
NCT01495351 | Multiple Myeloma | Phase 1 | Completed | - | Canada, Alberta ... more >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Collapse << |
NCT01477489 | Breast Cancer | Phase 1 | Completed | - | United States, Massachusetts ... more >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina Duke Durham, North Carolina, United States, 27710 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
NCT02009631 | Breast Cancer ... more >> Ovarian Cancer Colon Cancer Lung Cancer Gastric Cancer Solid Tumors Collapse << | Phase 1 | Completed | - | United States, Arizona ... more >> Site Reference ID/Investigator# 116015 Scottsdale, Arizona, United States, 85258 United States, Texas Site Reference ID/Investigator# 116016 San Antonio, Texas, United States, 78229 Netherlands Site Reference ID/Investigator# 117320 Groningn, Netherlands, 9713 GZ Site Reference ID/Investigator# 117336 Maastricht, Netherlands, 6229 HX Spain Site Reference ID/Investigator# 117517 Madrid, Spain, 28050 Collapse << |
NCT01017640 | Solid Neoplasm | Phase 1 | Completed | - | United States, Kentucky ... more >> Georgetown Cancer Treatment Center Georgetown, Kentucky, United States, 40324 United States, Ohio Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Collapse << |
NCT00588991 | Adult Acute Megakaryoblastic L... more >>eukemia Adult Acute Monoblastic Leukemia Adult Acute Monocytic Leukemia Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With Maturation Adult Acute Myeloid Leukemia With Minimal Differentiation Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1 Adult Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A Adult Acute Myeloid Leukemia Without Maturation Adult Acute Myelomonocytic Leukemia Adult Erythroleukemia Adult Pure Erythroid Leukemia Chronic Myelomonocytic Leukemia de Novo Myelodysplastic Syndrome Essential Thrombocythemia Hematopoietic and Lymphoid Cell Neoplasm Myelodysplastic Syndrome Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia Polycythemia Vera Previously Treated Myelodysplastic Syndrome Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Disease Secondary Myelodysplastic Syndrome Collapse << | Phase 1 | Active, not recruiting | - | United States, Maryland ... more >> Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Collapse << |
NCT01145430 | Estrogen Receptor Negative ... more >> HER2/Neu Negative Male Breast Carcinoma Progesterone Receptor Negative Recurrent Breast Carcinoma Recurrent Fallopian Tube Carcinoma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Stage IV Breast Cancer AJCC v6 and v7 Triple-Negative Breast Carcinoma Collapse << | Phase 1 | Completed | - | United States, New York ... more >> Montefiore Medical Center-Einstein Campus Bronx, New York, United States, 10461 Montefiore Medical Center - Moses Campus Bronx, New York, United States, 10467-2490 Laura and Isaac Perlmutter Cancer Center at NYU Langone New York, New York, United States, 10016 Mount Sinai Hospital New York, New York, United States, 10029 Columbia University/Herbert Irving Cancer Center New York, New York, United States, 10032 Weill Medical College of Cornell University New York, New York, United States, 10065 Collapse << |
NCT01104259 | Estrogen Receptor-negative Bre... more >>ast Cancer HER2-negative Breast Cancer Hereditary Breast/Ovarian Cancer - BRCA1 Hereditary Breast/Ovarian Cancer - BRCA2 Male Breast Cancer Progesterone Receptor-negative Breast Cancer Recurrent Breast Cancer Stage IV Breast Cancer Triple-negative Breast Cancer Collapse << | Phase 1 | Completed | - | United States, Washington ... more >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Collapse << |
NCT01205828 | - | - | Terminated(Lack of efficacy) | - | - |
NCT01282333 | Advanced Adult Primary Liver C... more >>ancer Localized Unresectable Adult Primary Liver Cancer Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter Regional Transitional Cell Cancer of the Renal Pelvis and Ureter Stage III Bladder Cancer Stage III Pancreatic Cancer Stage IIIA Non-small Cell Lung Cancer Stage IIIB Non-small Cell Lung Cancer Stage IV Bladder Cancer Stage IV Non-small Cell Lung Cancer Stage IV Pancreatic Cancer Transitional Cell Carcinoma of the Bladder Unresectable Extrahepatic Bile Duct Cancer Unresectable Gallbladder Cancer Collapse << | Phase 1 | Terminated | - | United States, Massachusetts ... more >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Pennsylvania Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15232 Collapse << |
NCT02163694 | Metastatic Breast Cancer | Phase 3 | Active, not recruiting | May 30, 2019 | - |
NCT01139970 | Accelerated Phase of Disease ... more >> Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1 Adult Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A Adult Acute Promyelocytic Leukemia With PML-RARA Adult B Acute Lymphoblastic Leukemia Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Adult T Acute Lymphoblastic Leukemia Alkylating Agent-Related Acute Myeloid Leukemia Blastic Phase Chronic Myelomonocytic Leukemia Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Disease Secondary Acute Myeloid Leukemia Untreated Adult Acute Lymphoblastic Leukemia Untreated Adult Acute Myeloid Leukemia Collapse << | Phase 1 | Active, not recruiting | - | United States, Illinois ... more >> University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 United States, Maryland University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 Collapse << |
NCT02106546 | Squamous Non-Small Cell Lung C... more >>ancer Collapse << | Phase 3 | Active, not recruiting | July 15, 2019 | - |
NCT01149083 | BRCA1 Mutation Carrier ... more >> BRCA2 Mutation Carrier Recurrent Breast Carcinoma Stage IIIB Breast Cancer AJCC v7 Stage IIIC Breast Cancer AJCC v7 Stage IV Breast Cancer AJCC v6 and v7 Collapse << | Phase 2 | Active, not recruiting | - | United States, California ... more >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 USC / Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 United States, Colorado University of Colorado Hospital Aurora, Colorado, United States, 80045 United States, Florida Mayo Clinic in Florida Jacksonville, Florida, United States, 32224-9980 United States, Illinois University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 United States, Maryland Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 United States, Massachusetts Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Missouri Siteman Cancer Center at Washington University Saint Louis, Missouri, United States, 63110 Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Montefiore Medical Center-Einstein Campus Bronx, New York, United States, 10461 Montefiore Medical Center - Moses Campus Bronx, New York, United States, 10467 Laura and Isaac Perlmutter Cancer Center at NYU Langone New York, New York, United States, 10016 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Weill Medical College of Cornell University New York, New York, United States, 10065 United States, Pennsylvania Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 UPMC-Magee Womens Hospital Pittsburgh, Pennsylvania, United States, 15213 University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States, 15232 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 Canada, Ontario University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Collapse << |
NCT02944396 | Non-Small Cell Lung Cancer | Phase 1 Phase 2 | Active, not recruiting | January 2, 2019 | United States, Alabama ... more >> University of Alabama /ID# 155135 Birmingham, Alabama, United States, 35233 United States, California Icri /Id# 155593 Whittier, California, United States, 90603 United States, Colorado Univ of Colorado Cancer Center /ID# 153820 Aurora, Colorado, United States, 80045 United States, Illinois University of Chicago /ID# 153824 Chicago, Illinois, United States, 60637-1443 United States, Indiana Goshen Center for Cancer Care /ID# 153822 Goshen, Indiana, United States, 46526 United States, North Carolina Duke Univ Med Ctr /ID# 153821 Durham, North Carolina, United States, 27710 Collapse << |
NCT03061188 | Advanced Solid Neoplasm ... more >> Aggressive Non-Hodgkin Lymphoma Recurrent Solid Neoplasm Refractory Mantle Cell Lymphoma T-Cell Non-Hodgkin Lymphoma Unresectable Solid Neoplasm Collapse << | Phase 1 | Recruiting | January 2021 | United States, Illinois ... more >> Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Young K. Chae, MD, MPH, MBA 312-695-0370 Principal Investigator: Young K. Chae, MD, MPH, MBA Sub-Investigator: Benedito Carneiro, MD Sub-Investigator: Sunandana Chandra, MD Sub-Investigator: Jason Kaplan, MD Sub-Investigator: Aparna Kalyan, MD Sub-Investigator: Sarika Jain, MD Sub-Investigator: Massimo Cristofanilli, MD Sub-Investigator: Victoria Villaflor, MD Sub-Investigator: Cesar Santa-Maria, MD Sub-Investigator: Ricardo Costa, MD Sub-Investigator: Valerie Nelson, MD Sub-Investigator: Neal Christiansen, MD Sub-Investigator: Alok Pant, MD Sub-Investigator: Amanda Williams, PA Sub-Investigator: Hannah Garret, APN Sub-Investigator: Ellen Dammrich, APN Sub-Investigator: Mark Agulnik, MD Sub-Investigator: Frank Giles, MD Collapse << |
NCT00892736 | Basal-Like Breast Carcinoma ... more >> BRCA1 Mutation Carrier BRCA2 Mutation Carrier Breast Carcinoma Estrogen Receptor Negative HER2/Neu Negative Hereditary Breast and Ovarian Cancer Syndrome Ovarian Carcinoma Pancreatic Carcinoma Progesterone Receptor Negative Prostate Carcinoma Recurrent Breast Carcinoma Recurrent Fallopian Tube Carcinoma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Solid Neoplasm Triple-Negative Breast Carcinoma Collapse << | Phase 1 | Completed | - | United States, California ... more >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 USC / Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 City of Hope South Pasadena South Pasadena, California, United States, 91030 United States, New Jersey Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 United States, Pennsylvania Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States, 15232 Collapse << |
NCT01472783 | Recurrent, Epithelial Ovarian ... more >>Cancer Collapse << | Phase 1 Phase 2 | Completed | - | Denmark ... more >> Department of Oncology, Vejle Hospital Vejle, Denmark, 7100 Collapse << |
NCT01009788 | Breast Cancer ... more >> Metastatic Breast Cancer BRCA1 Gene Mutation brca2 Gene Mutation Collapse << | Phase 2 | Active, not recruiting | June 2020 | United States, Massachusetts ... more >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Collapse << |
NCT01233505 | Adenocarcinoma of the Pancreas... more >> Adenocarcinoma of the Stomach BRCA1 Mutation Carrier BRCA2 Mutation Carrier Ovarian Mucinous Cystadenocarcinoma Recurrent Breast Cancer Recurrent Colon Cancer Recurrent Gastric Cancer Recurrent Ovarian Epithelial Cancer Recurrent Ovarian Germ Cell Tumor Recurrent Pancreatic Cancer Recurrent Rectal Cancer Stage IA Breast Cancer Stage IB Breast Cancer Stage II Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Stage IV Breast Cancer Stage IV Colon Cancer Stage IV Gastric Cancer Stage IV Ovarian Epithelial Cancer Stage IV Ovarian Germ Cell Tumor Stage IV Pancreatic Cancer Stage IV Rectal Cancer Unspecified Adult Solid Tumor, Protocol Specific Collapse << | Phase 1 | Terminated | - | United States, Wisconsin ... more >> University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Collapse << |
NCT01657799 | Brain Metastases From Non-smal... more >>l Cell Lung Cancer Collapse << | Phase 2 | Completed | - | - |
NCT01657799 | - | - | Completed | - | - |
NCT02412371 | Non-small Cell Lung Cancer Sta... more >>ge III Collapse << | Phase 1 Phase 2 | Active, not recruiting | February 28, 2019 | United States, California ... more >> Ucsd /Id# 133037 La Jolla, California, United States, 92037 United States, Delaware Christiana Care Health Service /ID# 133486 Newark, Delaware, United States, 19713 United States, Illinois University of Chicago /ID# 133828 Chicago, Illinois, United States, 60637-1443 United States, Maryland Univ Maryland School Medicine /ID# 132944 Baltimore, Maryland, United States, 21201 United States, Massachusetts Dana-Farber Cancer Institute /ID# 133494 Boston, Massachusetts, United States, 02215 United States, New York SUNY Upstate Medical Center /ID# 133492 Syracuse, New York, United States, 13210 United States, North Carolina Unc /Id# 133496 Chapel Hill, North Carolina, United States, 27599 Duke Univ Med Ctr /ID# 133497 Durham, North Carolina, United States, 27710 Wake Forest Univ HS /ID# 134608 Winston-Salem, North Carolina, United States, 27157 United States, Rhode Island Rhode Island Hospital /ID# 133493 Providence, Rhode Island, United States, 02903 The Miriam Hospital /ID# 133910 Providence, Rhode Island, United States, 02906 United States, Virginia University of Virginia /ID# 133495 Charlottesville, Virginia, United States, 22908 Collapse << |
NCT01193140 | Solid Tumor Cancers | Phase 2 | Completed | - | United States, California ... more >> Site Reference ID/Investigator# 43022 Encinitas, California, United States, 92024 Site Reference ID/Investigator# 42662 Santa Monica, California, United States, 90404 Collapse << |
NCT02595905 | Breast Carcinoma Metastatic in... more >> the Brain Deleterious BRCA1 Gene Mutation Deleterious BRCA2 Gene Mutation Estrogen Receptor Negative HER2/Neu Negative Progesterone Receptor Negative Recurrent Breast Carcinoma Stage IV Breast Cancer AJCC v6 and v7 Triple-Negative Breast Carcinoma Collapse << | Phase 2 | Recruiting | - | - |
NCT01589419 | Locally Advanced Rectal Cancer | Phase 1 | Completed | - | United States, Arizona ... more >> Site Reference ID/Investigator# 99095 Scottsdale, Arizona, United States, 85258 United States, Illinois Site Reference ID/Investigator# 68044 Chicago, Illinois, United States, 60611 United States, Indiana Site Reference ID/Investigator# 112395 Goshen, Indiana, United States, 46526 United States, North Carolina Site Reference ID/Investigator# 68045 Durham, North Carolina, United States, 27710 United States, Wisconsin Site Reference ID/Investigator# 68043 Madison, Wisconsin, United States, 53792 Australia Site Reference ID/Investigator# 67882 East Melbourne, Australia, 3002 Collapse << |
NCT02483104 | Ovarian Cancer | Phase 1 | Completed | - | Japan ... more >> Site Reference ID/Investigator# 128815 Kurume-shi,Fukuoka, Japan Site Reference ID/Investigator# 128997 Morioka-shi, Japan Site Reference ID/Investigator# 128058 Nagaizumi-cho, Japan Collapse << |
NCT01434316 | Advanced Malignant Solid Neopl... more >>asm BRCA1 Gene Mutation BRCA2 Gene Mutation Collapse << | Phase 1 | Recruiting | - | United States, Massachusetts ... more >> Massachusetts General Hospital Cancer Center Recruiting Boston, Massachusetts, United States, 02114 Contact: Geoffrey I. Shapiro 617-632-4942 geoffrey_shapiro@dfci.harvard.edu Principal Investigator: Geoffrey I. Shapiro Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Scott J. Rodig 617-525-7825 srodig@partners.org Principal Investigator: Scott J. Rodig Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Gerburg M. Wulf 617-667-9925 Sub-Investigator: Gerburg M. Wulf Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Geoffrey I. Shapiro 617-632-4942 geoffrey_shapiro@dfci.harvard.edu Principal Investigator: Geoffrey I. Shapiro Massachusetts General Hospital Recruiting Charlestown, Massachusetts, United States, 02129 Contact: Jeffrey Supko 617-724-1970 jsupko@partners.org Principal Investigator: Jeffrey Supko Collapse << |
NCT03581292 | Anaplastic Astrocytoma ... more >> Glioblastoma Malignant Glioma Collapse << | Phase 2 | Recruiting | October 29, 2024 | - |
NCT01199224 | Solid Tumors | Phase 1 | Completed | - | - |
NCT03032614 | Breast Cancer Stage IV ... more >> Ovarian Cancer BRCA1 Mutation BRCA2 Mutation Collapse << | Phase 2 | Withdrawn(Lack of funding) | April 30, 2020 | - |
NCT01540565 | BRCA1 Mutation Carrier ... more >> BRCA2 Mutation Carrier Ovarian Epithelial Tumor Recurrent Fallopian Tube Carcinoma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Collapse << | Phase 2 | Completed | - | - |
NCT02631733 | Malignant Solid Neoplasm | Phase 1 | Recruiting | - | United States, Maryland ... more >> Johns Hopkins University/Sidney Kimmel Cancer Center Recruiting Baltimore, Maryland, United States, 21287 Contact: Site Public Contact 410-955-8804 jhcccro@jhmi.edu Principal Investigator: Roisin M. Connolly National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: Site Public Contact 800-411-1222 Principal Investigator: Anish Thomas NCI - Center for Cancer Research Recruiting Bethesda, Maryland, United States, 20892 Contact: Site Public Contact 800-411-1222 Principal Investigator: Anish Thomas United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Site Public Contact 855-776-0015 Principal Investigator: Ciara C. O'Sullivan United States, New York Columbia University/Herbert Irving Cancer Center Recruiting New York, New York, United States, 10032 Contact: Site Public Contact 212-305-6361 nr2616@cumc.columbia.edu Principal Investigator: Susan E. Bates United States, Ohio Cleveland Clinic Foundation Suspended Cleveland, Ohio, United States, 44195 Collapse << |
NCT01351909 | HER2/Neu Negative ... more >> Recurrent Breast Carcinoma Stage IIIB Breast Cancer AJCC v7 Stage IIIC Breast Cancer AJCC v7 Stage IV Breast Cancer AJCC v6 and v7 Collapse << | Phase 1 | Active, not recruiting | - | United States, New York ... more >> Montefiore Medical Center-Einstein Campus Bronx, New York, United States, 10461 Montefiore Medical Center-Weiler Hospital Bronx, New York, United States, 10461 Montefiore Medical Center - Moses Campus Bronx, New York, United States, 10467 Laura and Isaac Perlmutter Cancer Center at NYU Langone New York, New York, United States, 10016 Columbia University/Herbert Irving Cancer Center New York, New York, United States, 10032 Collapse << |
NCT03044795 | Cancer | Phase 2 | Not yet recruiting | November 2020 | Netherlands ... more >> University Medical Center Groningen Not yet recruiting Groningen, Netherlands, 9713 GZ Contact: J. A. Gietema, MD, PhD +31 50 3612821 j.a.gietema@umcg.nl Contact: M. Jalving, MD, PhD +31 50 3612821 m.jalving@umcg.nl Principal Investigator: J. A. Gietema, MD, PhD Erasmus MC Not yet recruiting Rotterdam, Netherlands Contact: A. Jager, MD, PhD +31 10 7041733 a.jager@erasmusmc.nl Principal Investigator: A. Jager, MD, PhD Collapse << |
NCT01908478 | Pancreatic Cancer | Phase 1 | Active, not recruiting | July 2020 | United States, California ... more >> Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 Collapse << |
NCT01690598 | Ovarian Cancer | Phase 1 Phase 2 | Completed | - | Denmark ... more >> Department of Oncology, Vejle Hospital Vejle, Denmark, DK-7100 Collapse << |
NCT02860819 | Testicular Cancer | Phase 2 | Recruiting | December 2018 | Slovakia ... more >> National Cancer Institute Recruiting Bratislava, Slovakia, 83310 Contact: Michal Mego, Assoc. Prof +421259378 ext 366 michal.mego@nou.sk Contact: Jozef Mardiak, Prof +421259378 ext 108 jozef.mardiak@nou.sk Principal Investigator: Jozef Mardiak, Prof Principal Investigator: Michal Mego, Assoc. Prof Collapse << |
NCT03123211 | - | - | - | - | - |
NCT01123876 | Gastric Cancer | Phase 1 | Completed | - | United States, Arizona ... more >> Site Reference ID/Investigator# 24987 Scottsdale, Arizona, United States, 85258 United States, California Site Reference ID/Investigator# 24985 Los Angeles, California, United States, 90033 Site Reference ID/Investigator# 26742 Los Angeles, California, United States, 90033 United States, District of Columbia Site Reference ID/Investigator# 24986 Washington, District of Columbia, United States, 20007 United States, North Carolina Site Reference ID/Investigator# 24922 Durham, North Carolina, United States, 27710 United States, Tennessee Site Reference ID/Investigator# 24983 Nashville, Tennessee, United States, 37232-6868 Korea, Republic of Site Reference ID/Investigator# 75713 Seoul, Korea, Republic of, 138-736 Site Reference ID/Investigator# 75714 Seoul, Korea, Republic of Collapse << |
NCT02723864 | Neoplasms | Phase 1 | Recruiting | December 31, 2020 | United States, Maryland ... more >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 United States, Massachusetts Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030-4096 Collapse << |
NCT02158507 | Metastatic Triple Negative Bre... more >>ast Cancer Collapse << | Not Applicable | Active, not recruiting | September 1, 2020 | United States, Alabama ... more >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 Collapse << |
NCT01853306 | Oncology BRCA... more >> Mutated High Grade Serous Ovarian Cancer BRCA Mutated Breast Cancer Collapse << | Phase 1 | Completed | - | - |
NCT02210663 | Advanced Solid Tumors | Phase 1 | Completed | - | Japan ... more >> Site Reference ID/Investigator# 128056 Hidaka-shi, Japan Site Reference ID/Investigator# 129976 Hyogo, Japan Site Reference ID/Investigator# 128057 Tokyo, Japan Collapse << |
NCT02289690 | Small Cell Lung Cancer | Phase 1 Phase 2 | Active, not recruiting | March 27, 2019 | - |
靶点 | Description | IC50 |
---|---|---|
PARP1 | Ki:5.2nM | |
PARP2 | Ki:2.9nM |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网